Last updated on December 2019

A Phase 3 Multi-Center Randomized Double-Blind Placebo-Controlled Study of Fostamatinib Disodium in the Treatment of wAIHA

Brief description of study

The primary objective of this study is to assess the efficacy of fostamatinib in subjects with warm antibody autoimmune hemolytic anemia (wAIHA).

Clinical Study Identifier: NCT03764618

Find a site near you

Start Over

The Alfred Hospital

Melbourne, Australia
  Connect »